What is NDC 70710-1769?

70710-1769 is the product NDC for Leuprolide Acetate kit, listed with the FDA by Zydus Pharmaceuticals USA Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Zydus Pharmaceuticals USA Inc., NDC labeler code 70710. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Leuprolide Acetate?

11 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Leuprolide Acetate NDC 70710-1769 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)70710-1769Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70710-1769Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70710-1769-3	7071017690370710176903	1 KIT in 1 CARTON (70710-1769-3) * 1 VIAL, MULTI-DOSE in 1 CARTON (70710-1768-1) / 2.8 mL in 1 VIAL, MULTI-DOSE * 1 mL in 1 PACKET (70710-1897-8)Marketed from Jan 8, 2026

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Leuprolide Acetate
Generic name (nonproprietary): leuprolide acetate
Dosage form: Kit
Labeler: Zydus Pharmaceuticals USA Inc.NDC labeler code 70710
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 215826
Marketing start: Jan 8, 2026
Listing expires: Dec 31, 2027
Identifiers: Product ID 70710-1769_fc662130-c2dd-4ff3-829b-9af6c52c5fafSPL ID fc662130-c2dd-4ff3-829b-9af6c52c5fafSPL set ID 35634415-000f-47db-9bd7-9e16eef3f02eRxCUI 545835, 797544

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N470710176903 followed by a unit qualifier and the quantity

Package 70710-1769-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 25, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Leuprolide acetate injection is indicated in the palliative treatment of advanced prostatic cancer.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 70710-1769

What is NDC 70710-1769?: 70710-1769 is the product NDC for Leuprolide Acetate kit, listed with the FDA by Zydus Pharmaceuticals USA Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Leuprolide Acetate.
Who is the labeler?: Zydus Pharmaceuticals USA Inc., NDC labeler code 70710. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Leuprolide Acetate?: 11 other product NDCs are listed under this name. See all Leuprolide Acetate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Leuprolide Acetate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Leuprolide Acetate	Leuprolide acetate 1 mg/.2mL	InjectionSubcutaneous	Endo USA, Inc.	42023-259	42023-0259-00
Leuprolide Acetate	—	Kit	Zydus Lifesciences Limited	70771-1687	70771-1687-03
leuprolide acetate	—	KitSubcutaneous	PAI Holdings, LLC dba PAI Pharma	0121-2106	00121-2106-02
leuprolide acetate	—	KitSubcutaneous	UBI Pharma Inc.	72843-591	72843-0591-99
Leuprolide Acetate	—	KitSubcutaneous	Meitheal Pharmaceuticals Inc	71288-569	71288-0569-90
Leuprolide Acetate	—	KitSubcutaneous	NorthStar RxLLC	72603-344	72603-0344-01
leuprolide acetate	—	KitSubcutaneous	Amneal Pharmaceuticals LLC	70121-2537	70121-2537-06
Leuprolide Acetate	—	Kit	Eugia US LLC	55150-478	55150-0478-01
Leuprolide Acetate	—	Kit	VGYAAN Pharmaceuticals LLC	72664-611	72664-0611-28
leuprolide acetate	—	Kit	Sun Pharmaceutical Industries, Inc.	47335-936	47335-0936-40

All 12 Leuprolide Acetate NDCs

Other NDCs under ANDA 215826

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 215826
Product	Strength	Form · route	Labeler	Product NDC
Leuprolide Acetate	—	Kit	Zydus Lifesciences Limited	70771-1687